An innovative spray helped men with premature ejaculation last six times longer, a new study says.
The study tested the effectiveness of the PSD502 spray, developed to prolong sexual intercourse
for men diagnosed with premature ejaculation. The PSD502 spray
contains two drugs lidocaine and prilocaine and is applied locally five minutes before the intercourse.
Almost every man faces the problem of premature ejaculation
at least once in his lifetime. Premature ejaculation is an inability to control ejaculation, which usually occurs shortly after sexual intercourse begins or prior to it.
Scientists say that premature ejaculation may be an inherited disorder linked to genes.
A study conducted by Finnish researchers Pekka Santtila, Kenneth Sandnabba and Patrick Jern revealed that many men faced the problem of premature ejaculation
and erectile dysfunction
at their fist sexual experience.
A novel drug to treat premature ejaculation
was approved and is now available in New Zealand pharmacies.
a drug containing dapoxetine hydrochloride
is recommended for men with premature ejaculation aged 18 to 64.